Ask the Expert

Burden of Multiple Myeloma

Treatment resources

Clinical trials

Download the ClinTrial Refer App

Latest News

Wave of New Therapies Improve Outcomes for Patients with Multiple Myeloma

This article was originally published by Cancer Health New drugs to treat multiple myeloma are producing better results for patients,...
Continue Reading

Exploring Challenges With CAR T Cells and NK Cells in Multiple Myeloma

This article was originally published by Targeted Oncology. C. Ola Landgren, MD, PhD, chief of Myeloma Service and hematologic oncologist at...
Continue Reading

Upcoming patient seminar: Hamilton

Hamilton Myeloma Semimar, Saturday 5 September Come along to our Hamilton Myeloma Patient Seminar, hosted by MyelomaNew Zealand and Leukaemia...
Continue Reading

GSK nabs FDA approval for first-in-class multiple myeloma drug

Blenrep, an antibody-drug conjugate, is the first drug approved for multiple myeloma that targets the antigen BCMA. Several other companies...
Continue Reading

Wave of New Therapies Improve Outcomes for Patients with Multiple Myeloma

For many patients with multiple myeloma, a new generation of drugs and drug combinations is producing better outcomes and fewer...
Continue Reading

“Good-Risk” Group of Patients With Myeloma Saw Better Outcomes

This article was originally published by Cancer Therapy Advisor Researchers have used deep whole-genome sequencing (WGS) to identify genomic markers...
Continue Reading

Subscribe

Every quarter we’ll post news and information in our myeloma newsletter. If you would like to join the community of patients and caregivers receiving this subscribe below.

Videos